{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:14:27Z","timestamp":1778692467840,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This review of reviews aimed to appraise the use of the CONSORT-PRO Extension as an evaluation tool for assessing the reporting of patient-reported outcome (PROs) in publications, and to describe the reporting of PRO research across reviews. We also outlined how variation in such evaluations impacts knowledge translation and may lead to potential misuse of the CONSORT-PRO Extension. We systematically searched Medline, Pubmed and CINAHL from 2013 to 2025 March 2021 for reviews of the completeness of reporting of PRO endpoints according to CONSORT-PRO criteria. Two reviewers extracted details of each review, the percentage of included studies that addressed each CONSORT-PRO item, and key recommendations from each review. Fourteen reviews met inclusion criteria, and only six of these used the full CONSORT-PRO checklist with minimal justified modifications. The remaining eight studies made significant or unjustified adjustments to the CONSORT-PRO Extension. Review studies also varied in how they scored multi-component CONSORT-PRO items. CONSORT-PRO items were often unreported in trial reports, and certain CONSORT-PRO items were reported less often than others. The reporting of statistical approaches to dealing with missing PRO data were poor in RCTs included in all 14 review articles. Studies reviewing PRO publications often omitted recommended CONSORT-PRO items from their evaluations, which may cause confusion among readers regarding how best to report their PRO research according to the CONSORT-PRO extension. Many trials published since CONSORT-PRO\u2019s release did not report recommended CONSORT-PRO items, which may lead to misinterpretation and consequently to research waste.<\/jats:p>","DOI":"10.1007\/s11136-022-03119-w","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:32:33Z","timestamp":1648528353000},"page":"2939-2957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-9099","authenticated-orcid":false,"given":"Rebecca","family":"Mercieca-Bebber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9122-8251","authenticated-orcid":false,"given":"Olalekan Lee","family":"Aiyegbusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2887","authenticated-orcid":false,"given":"Madeleine T.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-4561","authenticated-orcid":false,"given":"Claire","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-837X","authenticated-orcid":false,"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"issue":"5","key":"3119_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11136-010-9793-3","volume":"20","author":"M Brundage","year":"2011","unstructured":"Brundage, M., Bass, B., Davidson, J., Queenan, J., Bezjak, A., Ringash, J., Wilkinson, A., & Feldman-Stewart, D. (2011). Patterns of reporting health-related quality of life outcomes in randomized clinical trials: Implications for clinicians and quality of life researchers. Quality of Life Research, 20(5), 653\u2013664.","journal-title":"Quality of Life Research"},{"issue":"12","key":"3119_CR2","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdm121","volume":"18","author":"F Joly","year":"2007","unstructured":"Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and\/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18(12), 1935\u20131942.","journal-title":"Annals of Oncology"},{"issue":"9913","key":"3119_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0140-6736(13)62228-X","volume":"383","author":"P Glasziou","year":"2014","unstructured":"Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014). Reducing waste from incomplete or unusable reports of biomedical research. The Lancet, 383(9913), 267\u2013276.","journal-title":"The Lancet"},{"issue":"9912","key":"3119_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(13)62227-8","volume":"383","author":"JPA Ioannidis","year":"2014","unstructured":"Ioannidis, J. P. A., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., Schulz, K. F., & Tibshirani, R. (2014). Increasing value and reducing waste in research design, conduct, and analysis. The Lancet, 383(9912), 166\u2013175.","journal-title":"The Lancet"},{"issue":"9913","key":"3119_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0140-6736(13)62296-5","volume":"383","author":"A-W Chan","year":"2014","unstructured":"Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., G\u00f8tzsche, P. C., Krumholz, H. M., Ghersi, D., & Van Der Worp, H. B. (2014). Increasing value and reducing waste: Addressing inaccessible research. The Lancet, 383(9913), 257\u2013266.","journal-title":"The Lancet"},{"issue":"11","key":"3119_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/jnci\/djz038","volume":"111","author":"D Kyte","year":"2019","unstructured":"Kyte, D., Retzer, A., Ahmed, K., Keeley, T., Armes, J., Brown, J. M., Calman, L., Gavin, A., Glaser, A. W., Greenfield, D. M., & Lanceley, A. (2019). Systematic evaluation of patient-reported outcome protocol content and reporting in cancer trials. Journal of the National Cancer Institute. Monographs, 111(11), 1170\u20131178.","journal-title":"Journal of the National Cancer Institute. Monographs"},{"issue":"9","key":"3119_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/annonc\/mdv283","volume":"26","author":"S Schandelmaier","year":"2015","unstructured":"Schandelmaier, S., Conen, K., von Elm, E., You, J. J., Blumle, A., Tomonaga, Y., Amstutz, A., Briel, M., Kasenda, B., Saccilotto, R., & Bengough, T. (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 26(9), 1966\u20131973. https:\/\/doi.org\/10.1093\/annonc\/mdv283","journal-title":"Annals of Oncology"},{"key":"3119_CR8","unstructured":"EQUATOR Network (2022) What is a reporting guideline? Retrieved from https:\/\/www.equator-network.org\/about-us\/what-is-a-reporting-guideline\/."},{"issue":"2","key":"3119_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11060-012-0819-2","volume":"108","author":"F Efficace","year":"2012","unstructured":"Efficace, F., & Taphoorn, M. (2012). Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: The challenge of brain cancer studies. Journal of Neuro-Oncology, 108(2), 221\u2013226.","journal-title":"Journal of Neuro-Oncology"},{"issue":"18","key":"3119_CR10","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1200\/JCO.2003.12.121","volume":"21","author":"FBA Efficace","year":"2003","unstructured":"Efficace, F. B. A., Osoba, D., Gotay, C., Flechtner, H., D\u2019Haese, S., & Zurlo, A. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials\u2013does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21(18), 3502\u20133511.","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"3119_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"M Calvert","year":"2013","unstructured":"Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., & Brundage, M. D. (2013). Reporting of patient-reported outcomes in randomized trials: The CONSORT-PRO extension. JAMA, 309(8), 814\u2013822.","journal-title":"JAMA"},{"key":"3119_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-184","author":"M Calvert","year":"2013","unstructured":"Calvert, M., Brundage, M., Jacobsen, P. B., Schunemann, H. J., & Efficace, F. (2013). The CONSORT patient-reported outcome (PRO) extension: implications for clinical trials and practice. Health and Quality of Life Outcomes. https:\/\/doi.org\/10.1186\/1477-7525-11-184","journal-title":"Health and Quality of Life Outcomes"},{"key":"3119_CR13","unstructured":"EQUATOR Network. Enhancing the quality and transparency of health research. Retrieved from http:\/\/www.equator-network.org\/."},{"key":"3119_CR14","volume-title":"Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: The use of patient-reported outcome (PRO) measures in oncology studies","author":"European Medicines Agency","year":"2016","unstructured":"European Medicines Agency. (2016). Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: The use of patient-reported outcome (PRO) measures in oncology studies. European Medicines Agency."},{"issue":"1","key":"3119_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/annonc\/mdu489","volume":"26","author":"O Bylicki","year":"2014","unstructured":"Bylicki, O., Gan, H. K., Joly, F., Maillet, D., You, B., & P\u00e9ron, J. (2014). Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. Annals of Oncology, 26(1), 231\u2013237.","journal-title":"Annals of Oncology"},{"issue":"18","key":"3119_CR16","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1002\/cncr.29489","volume":"121","author":"F Efficace","year":"2015","unstructured":"Efficace, F., Fayers, P., Pusic, A., Cemal, Y., Yanagawa, J., Jacobs, M., La Sala, A., Cafaro, V., Whale, K., Rees, J., & Blazeby, J. (2015). Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials. Cancer, 121(18), 3335\u20133342.","journal-title":"Cancer"},{"issue":"6","key":"3119_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s11136-017-1508-6","volume":"26","author":"R Mercieca-Bebber","year":"2017","unstructured":"Mercieca-Bebber, R., Rouette, J., Calvert, M., King, M. T., McLeod, L., Holch, P., Palmer, M. J., & Brundage, M. (2017). Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Quality of Life Research, 26(6), 1427\u20131437.","journal-title":"Quality of Life Research"},{"key":"3119_CR18","unstructured":"World Health Organization (2015) The evidence-informed policy network (EVIPNet) Europe. EVIPNet Europe strategic plan 2013\u201317. Retrieved February 28, 2022, from https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0009\/291636\/EVIPNet-Europe-strategic-plan-2013-17-en.pdf"},{"issue":"7","key":"3119_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., The PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097.","journal-title":"PLoS Medicine"},{"issue":"5","key":"3119_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","volume":"319","author":"M Calvert","year":"2018","unstructured":"Calvert, M., Kyte, D., Mercieca-Bebber, R., Slade, A., Chan, A. W., King, M. T., Hunn, A., Bottomley, A., Regnault, A., Ells, C., & O\u2019Connor, D. (2018). Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The spirit-pro extension. JAMA, 319(5), 483\u2013494.","journal-title":"JAMA"},{"issue":"4","key":"3119_CR21","first-page":"234","volume":"6","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Nagendran, M., Gomes, M., Wharton, P. V., Raine, R., & Lambiase, P. D. (2020). Gaps in patient-reported outcome measures in randomized clinical trials of cardiac catheter ablation: A systematic review. European Heart Journal, 6(4), 234\u2013242.","journal-title":"European Heart Journal"},{"issue":"6","key":"3119_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/1758573218791164","volume":"11","author":"JP Evans","year":"2019","unstructured":"Evans, J. P., Smith, C., Porter, I., Gangannagaripalli, J., Goodwin, V., & Valderas, J. (2019). Patient-centred outcomes in lateral elbow tendinopathy: A systematic review of available evidence in UK populations. Shoulder Elbow, 11(6), 440\u2013449.","journal-title":"Shoulder Elbow"},{"issue":"2","key":"3119_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00198-017-4249-z","volume":"29","author":"DE Mack","year":"2018","unstructured":"Mack, D. E., Wilson, P. M., Santos, E., & Brooks, K. (2018). Standards of reporting: The use of CONSORT PRO and CERT in individuals living with osteoporosis. Osteoporosis International, 29(2), 305\u2013313. https:\/\/doi.org\/10.1007\/s00198-017-4249-z","journal-title":"Osteoporosis International"},{"issue":"1","key":"3119_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12955-016-0527-2","volume":"14","author":"C Martini","year":"2016","unstructured":"Martini, C., Gamper, E. M., Wintner, L., Nilica, B., Sperner-Unterweger, B., Holzner, B., & Virgolini, I. (2016). Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours. Health and Quality of Life Outcomes, 14(1), 127.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"1","key":"3119_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41687-017-0008-3","volume":"1","author":"R Mercieca-Bebber","year":"2017","unstructured":"Mercieca-Bebber, R., Friedlander, M., Calvert, M., Stockler, M., Kyte, D., Kok, P.-S., & King, M. T. (2017). A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice. Journal of Patient-Reported Outcomes, 1(1), 5.","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"3119_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ctrv.2016.12.003","volume":"53","author":"M Dos Santos","year":"2017","unstructured":"Dos Santos, M., Brachet, P. E., Chevreau, C., & Joly, F. (2017). Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit. Cancer Treatment Reviews, 53, 53\u201360.","journal-title":"Cancer Treatment Reviews"},{"key":"3119_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fonc.2019.00715","volume":"9","author":"L Van Der Weijst","year":"2019","unstructured":"Van Der Weijst, L., Lievens, Y., Schrauwen, W., & Surmont, V. (2019). Health-related quality of life in advanced non-small cell lung cancer: A methodological appraisal based on a systematic literature review. Frontiers in Oncology, 9, 715.","journal-title":"Frontiers in Oncology"},{"issue":"6","key":"3119_CR28","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s11136-019-02392-6","volume":"29","author":"MR LeBlanc","year":"2020","unstructured":"LeBlanc, M. R., Hirschey, R., Leak Bryant, A., LeBlanc, T. W., & Smith, S. K. (2020). How are patient-reported outcomes and symptoms being measured in adults with relapsed\/refractory multiple myeloma? A systematic review. Quality of Life Research, 29(6), 1419\u20131431.","journal-title":"Quality of Life Research"},{"issue":"6","key":"3119_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/17512433.2016.1164595","volume":"9","author":"V Weingartner","year":"2016","unstructured":"Weingartner, V., Dargatz, N., Weber, C., Mueller, D., Stock, S., Voltz, R., & Gaertner, J. (2016). Patient reported outcomes in randomized controlled cancer trials in advanced disease: A structured literature review. Expert Review of Clinical Pharmacology, 9(6), 821\u2013829. https:\/\/doi.org\/10.1586\/17512433.2016.1164595","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"2","key":"3119_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00268-015-3292-1","volume":"40","author":"DJ Stevens","year":"2016","unstructured":"Stevens, D. J., Blencowe, N. S., McElnay, P. J., Macefield, R. C., Savovi\u0107, J., Avery, K. N., & Blazeby, J. M. (2016). A systematic review of patient-reported outcomes in randomized controlled trials of unplanned general surgery. World Journal of Surgery, 40(2), 267\u2013276.","journal-title":"World Journal of Surgery"},{"issue":"5","key":"3119_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/0962280213476378","volume":"23","author":"ML Bell","year":"2014","unstructured":"Bell, M. L., & Fairclough, D. L. (2014). Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research, 23(5), 440\u2013459.","journal-title":"Statistical Methods in Medical Research"},{"issue":"5\u20137","key":"3119_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<517::AID-SIM799>3.0.CO;2-S","volume":"17","author":"J Bernhard","year":"1998","unstructured":"Bernhard, J., Cella, D. F., Coates, A. S., Fallowfield, L., Ganz, P. A., Moinpour, C. M., Mosconi, P., Osoba, D., Simes, J., & H\u00fcrny, C. (1998). Missing quality of life data in cancer clinical trials: Serious problems and challenges. Statistics in Medicine, 17(5\u20137), 517\u2013532.","journal-title":"Statistics in Medicine"},{"issue":"5\u20137","key":"3119_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<633::AID-SIM810>3.0.CO;2-U","volume":"17","author":"J Bernhard","year":"1998","unstructured":"Bernhard, J., Gusset, H., & H\u00fcrny, C. (1998). Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research. Statistics in Medicine, 17(5\u20137), 633\u2013639.","journal-title":"Statistics in Medicine"},{"issue":"5\u20137","key":"3119_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<781::AID-SIM821>3.0.CO;2-O","volume":"17","author":"DL Fairclough","year":"1998","unstructured":"Fairclough, D. L., Peterson, H. F., Cella, D., & Bonomi, P. (1998). Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. Statistics in Medicine, 17(5\u20137), 781\u2013796.","journal-title":"Statistics in Medicine"},{"issue":"5\u20137","key":"3119_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<667::AID-SIM813>3.0.CO;2-6","volume":"17","author":"DL Fairclough","year":"1998","unstructured":"Fairclough, D. L., Peterson, H. F., & Chang, V. (1998). Why are missing quality of life data a problem in clinical trials of cancer therapy? Statistics in Medicine, 17(5\u20137), 667\u2013677.","journal-title":"Statistics in Medicine"},{"issue":"1","key":"3119_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1745-6215-9-51","volume":"9","author":"S Fielding","year":"2008","unstructured":"Fielding, S., Maclennan, G., Cook, J., & Ramsay, C. (2008). A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials, 9(1), 51.","journal-title":"Trials"},{"issue":"12","key":"3119_CR37","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11136-016-1411-6","volume":"25","author":"S Fielding","year":"2016","unstructured":"Fielding, S., Ogbuagu, A., Sivasubramaniam, S., MacLennan, G., & Ramsay, C. R. (2016). Reporting and dealing with missing quality of life data in RCTs: Has the picture changed in the last decade? Quality of Life Research, 25(12), 2977\u20132983.","journal-title":"Quality of Life Research"},{"issue":"6","key":"3119_CR38","first-page":"e010938","volume":"6","author":"R Mercieca-Bebber","year":"2016","unstructured":"Mercieca-Bebber, R., Palmer, M. J., Brundage, M., Calvert, M., Stockler, M. R., & King, M. T. (2016). Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: A systematic review. British Medical Journal Open, 6(6), e010938.","journal-title":"British Medical Journal Open"},{"key":"3119_CR39","volume-title":"Assessing quality of life in clinical trials","author":"D Revicki","year":"2005","unstructured":"Revicki, D., & Fairclough, D. (2005). Preventing missing data. In P. Fayers & R. D. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed.). New York: Oxford University Press.","edition":"2"},{"issue":"5\u20137","key":"3119_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<725::AID-SIM817>3.0.CO;2-1","volume":"17","author":"RJ Simes","year":"1998","unstructured":"Simes, R. J., Greatorex, V., & Gebski, V. J. (1998). Practical approaches to minimize problems with missing quality of life data. Statistics in Medicine, 17(5\u20137), 725\u2013737.","journal-title":"Statistics in Medicine"},{"issue":"2","key":"3119_CR41","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","volume":"21","author":"C Coens","year":"2020","unstructured":"Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., Cocks, K., Collette, L., & Devlin, N. (2020). International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: Recommendations of the SISAQOL consortium. The Lancet Oncology, 21(2), e83\u2013e96.","journal-title":"The Lancet Oncology"},{"issue":"1","key":"3119_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1740774517741113","volume":"15","author":"MJ Palmer","year":"2018","unstructured":"Palmer, M. J., Mercieca-Bebber, R., King, M., Calvert, M., Richardson, H., & Brundage, M. (2018). A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data. Clinical Trials., 15(1), 95\u2013106.","journal-title":"Clinical Trials."},{"issue":"7","key":"3119_CR43","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/078-0432.CCR-15-2035","volume":"22","author":"PG Kluetz","year":"2016","unstructured":"Kluetz, P. G., Slagle, A., Papadopoulos, E. J., Johnson, L. L., Donoghue, M., Kwitkowski, V. E., Chen, W. H., Sridhara, R., Farrell, A. T., Keegan, P., & Kim, G. (2016). Focusing on core patient-reported outcomes in cancer clinical trials: Symptomatic adverse events, physical function, and disease-related symptoms. Clinical Cancer Research, 22(7), 1553\u20131558. https:\/\/doi.org\/10.1158\/078-0432.CCR-15-2035","journal-title":"Clinical Cancer Research"},{"key":"3119_CR44","unstructured":"PROTEUS Consortium (2021) About PROTEUS 2021. Retrieved from https:\/\/more.bham.ac.uk\/proteus\/about-proteus\/"},{"issue":"11","key":"3119_CR45","first-page":"1863","volume":"48","author":"CONSORT PRO Group","year":"2020","unstructured":"CONSORT PRO Group. (2020). Japanese translation of reporting of patient-reported outcomes in randomized trials\u2014The CONSORT PRO extension. Japanese Pharmacology and Therapeutics, 48(11), 1863\u20131874.","journal-title":"Japanese Pharmacology and Therapeutics"},{"key":"3119_CR46","unstructured":"Cochrane Training, Pollock, M., Fernandes, R. M., Becker, L., Pieper, D., Hartling, L. (2022). Chapter V: Overviews of reviews: Cochrane training managing overlapping reviews 2022. Retrieved from https:\/\/training.cochrane.org\/handbook\/current\/chapter-v."}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-022-03119-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-022-03119-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-022-03119-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T18:51:16Z","timestamp":1663095076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-022-03119-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3119"],"URL":"https:\/\/doi.org\/10.1007\/s11136-022-03119-w","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"28 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests direcetly relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}